Microbix Biosystems Inc.
MBXBF
$0.16
$0.013.45%
OTC PK
| 09/30/2025 | 06/30/2025 | 03/31/2025 | 12/31/2024 | 09/30/2024 | |
|---|---|---|---|---|---|
| Revenue | -29.00% | -12.08% | -7.44% | 1.28% | 52.31% |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | -29.00% | -12.08% | -7.44% | 1.28% | 52.31% |
| Cost of Revenue | -15.11% | -9.14% | -14.33% | 0.54% | 9.63% |
| Gross Profit | -38.02% | -14.29% | -1.64% | 1.88% | 103.92% |
| SG&A Expenses | -5.54% | -4.44% | -9.82% | -11.79% | 13.76% |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | -8.79% | -5.70% | -10.61% | -4.45% | 10.66% |
| Operating Income | -140.74% | -75.18% | 45.54% | 123.29% | 240.90% |
| Income Before Tax | -162.12% | -103.40% | -58.69% | -45.14% | 15,788.95% |
| Income Tax Expenses | -136.68% | -- | -- | -- | -- |
| Earnings from Continuing Operations | -163.20% | -106.34% | -62.36% | -49.16% | 15,147.09% |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | -163.20% | -106.34% | -62.36% | -49.16% | 15,147.09% |
| EBIT | -140.74% | -75.18% | 45.54% | 123.29% | 240.90% |
| EBITDA | -100.55% | -48.27% | 25.26% | 65.12% | 391.55% |
| EPS Basic | -162.23% | -105.47% | -62.56% | -49.75% | 18,900.00% |
| Normalized Basic EPS | -160.48% | -98.39% | 72.73% | 228.57% | 216.98% |
| EPS Diluted | -165.96% | -107.30% | -62.96% | -50.00% | 2,450.00% |
| Normalized Diluted EPS | -160.48% | -98.39% | 72.73% | 228.57% | 216.98% |
| Average Basic Shares Outstanding | 0.11% | 1.46% | 0.65% | 0.02% | 0.26% |
| Average Diluted Shares Outstanding | -0.22% | 1.39% | 0.87% | -0.76% | -0.64% |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |